Subclinical Vitamin K Deficiency in Hemodialysis Patients
Background Subclinical vitamin K deficiency increasingly is associated with extraosseous calcification in healthy adults. Nondietary determinants of vitamin K status include apolipoprotein E (apoE) genotype, which may influence vitamin K transport to peripheral tissues. Methods Serum phylloquinone c...
Gespeichert in:
Veröffentlicht in: | American journal of kidney diseases 2007-03, Vol.49 (3), p.432-439 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 439 |
---|---|
container_issue | 3 |
container_start_page | 432 |
container_title | American journal of kidney diseases |
container_volume | 49 |
creator | Pilkey, Rachel M., MD Morton, A. Ross, MD Boffa, Michael B., PhD Noordhof, Curtis Day, Andrew G., MSc Su, Yinghua, BSc Miller, Lisa M., MD Koschinsky, Marlys L., PhD Booth, Sarah L., PhD |
description | Background Subclinical vitamin K deficiency increasingly is associated with extraosseous calcification in healthy adults. Nondietary determinants of vitamin K status include apolipoprotein E (apoE) genotype, which may influence vitamin K transport to peripheral tissues. Methods Serum phylloquinone concentrations and percentage of uncarboxyated osteocalcin (%ucOC) were measured by means of high-performance liquid chromatography and radioimmunoassay in 142 hemodialysis patients, respectively. ApoE phenotype was determined by means of isoelectric focusing of delipidated serum samples and Western blot analysis. Clinical and laboratory data were obtained by using chart review. Results Mean age was 62.6 ± 14.8 (SD) years. Mean phylloquinone level was 0.99 ± 1.12 nmol/L; 29% of patients had levels less than 0.4 nmol/L. There was no association between phylloquinone level and %ucOC. There were positive correlations between phylloquinone and total cholesterol ( P = 0.017), triglyceride ( P = 0.022), and ionized calcium levels ( P = 0.019). There was a negative correlation between phylloquinone level and dialysis adequacy ( P = 0.002). Mean %ucOC was 51.1% ± 25.8%, and 93% of subjects had values greater than 20%. There were positive correlations between %ucOC and dialysis vintage ( P < 0.001), phosphate level ( P < 0.001), parathyroid hormone level ( P < 0.001), albumin level ( P = 0.035), and ionized calcium level ( P = 0.046). Seventeen percent of patients were apoE4. Mean %ucOC was significantly greater in apoE4 carriers compared with all other apoE phenotypes (60.1% ± 28.4% versus 47.8% ± 24.4%; P = 0.035). In multiple regression analysis with phylloquinone level forced in, independent predictors of %ucOC were phosphate level, dialysis vintage, parathyroid hormone level, and apoE4. Conclusion These data indicate suboptimal vitamin K status in hemodialysis patients, shown by low phylloquinone concentrations and high %ucOC in 29% and 93% of subjects, respectively. The apoE4 allele influences osteocalcin γ-carboxylation in hemodialysis patients. |
doi_str_mv | 10.1053/j.ajkd.2006.11.041 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70219559</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S027263860601835X</els_id><sourcerecordid>70219559</sourcerecordid><originalsourceid>FETCH-LOGICAL-c439t-d275c1e2085bf51455a3eb7df9704eee39934175f0411c3f171199ef607fc7cb3</originalsourceid><addsrcrecordid>eNp9kV2L1TAQhoO4uMfVP-CF9Ebv2p1pmqYBEWT92MUFhVXxLqTpBNLtx5q0wvn3pp4jC3vhVRjyvDPDM4y9QCgQBD_vC9PfdkUJUBeIBVT4iO1QlDyvG948ZjsoZZnXvKlP2dMYewBQvK6fsFOUnNcSxI6pm7W1g5-8NUP2wy9m9FP2OXtPzltPk91nqb6kce68GfbRx-yrWdLHEp-xE2eGSM-P7xn7_vHDt4vL_PrLp6uLd9e5rbha8q6UwiKV0IjWCayEMJxa2TkloSIirhSvUAqX1kfLHUpEpcjVIJ2VtuVn7PWh712Yf60UFz36aGkYzETzGrWEEpUQKoHlAbRhjjGQ03fBjybsNYLehOleb8L0Jkwj6jQxhV4eu6_tSN195GgoAa-OgInJkQtmsj7ecwoBhNqmvzlwlFz89hR0_CuQOh_ILrqb_f_3ePsg_u8qt7Sn2M9rmJJljTqWGvTNdtrtslADNlz85H8A7RuciA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70219559</pqid></control><display><type>article</type><title>Subclinical Vitamin K Deficiency in Hemodialysis Patients</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Pilkey, Rachel M., MD ; Morton, A. Ross, MD ; Boffa, Michael B., PhD ; Noordhof, Curtis ; Day, Andrew G., MSc ; Su, Yinghua, BSc ; Miller, Lisa M., MD ; Koschinsky, Marlys L., PhD ; Booth, Sarah L., PhD</creator><creatorcontrib>Pilkey, Rachel M., MD ; Morton, A. Ross, MD ; Boffa, Michael B., PhD ; Noordhof, Curtis ; Day, Andrew G., MSc ; Su, Yinghua, BSc ; Miller, Lisa M., MD ; Koschinsky, Marlys L., PhD ; Booth, Sarah L., PhD</creatorcontrib><description>Background Subclinical vitamin K deficiency increasingly is associated with extraosseous calcification in healthy adults. Nondietary determinants of vitamin K status include apolipoprotein E (apoE) genotype, which may influence vitamin K transport to peripheral tissues. Methods Serum phylloquinone concentrations and percentage of uncarboxyated osteocalcin (%ucOC) were measured by means of high-performance liquid chromatography and radioimmunoassay in 142 hemodialysis patients, respectively. ApoE phenotype was determined by means of isoelectric focusing of delipidated serum samples and Western blot analysis. Clinical and laboratory data were obtained by using chart review. Results Mean age was 62.6 ± 14.8 (SD) years. Mean phylloquinone level was 0.99 ± 1.12 nmol/L; 29% of patients had levels less than 0.4 nmol/L. There was no association between phylloquinone level and %ucOC. There were positive correlations between phylloquinone and total cholesterol ( P = 0.017), triglyceride ( P = 0.022), and ionized calcium levels ( P = 0.019). There was a negative correlation between phylloquinone level and dialysis adequacy ( P = 0.002). Mean %ucOC was 51.1% ± 25.8%, and 93% of subjects had values greater than 20%. There were positive correlations between %ucOC and dialysis vintage ( P < 0.001), phosphate level ( P < 0.001), parathyroid hormone level ( P < 0.001), albumin level ( P = 0.035), and ionized calcium level ( P = 0.046). Seventeen percent of patients were apoE4. Mean %ucOC was significantly greater in apoE4 carriers compared with all other apoE phenotypes (60.1% ± 28.4% versus 47.8% ± 24.4%; P = 0.035). In multiple regression analysis with phylloquinone level forced in, independent predictors of %ucOC were phosphate level, dialysis vintage, parathyroid hormone level, and apoE4. Conclusion These data indicate suboptimal vitamin K status in hemodialysis patients, shown by low phylloquinone concentrations and high %ucOC in 29% and 93% of subjects, respectively. The apoE4 allele influences osteocalcin γ-carboxylation in hemodialysis patients.</description><identifier>ISSN: 0272-6386</identifier><identifier>EISSN: 1523-6838</identifier><identifier>DOI: 10.1053/j.ajkd.2006.11.041</identifier><identifier>PMID: 17336705</identifier><language>eng</language><publisher>Orlando, FL: Elsevier Inc</publisher><subject>Aged ; Alleles ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; apolipoprotein E ; Apolipoproteins E - genetics ; Apolipoproteins E - physiology ; Biological and medical sciences ; Biological Transport - physiology ; Cohort Studies ; Cross-Sectional Studies ; Emergency and intensive care: renal failure. Dialysis management ; Female ; hemodialysis ; Humans ; Intensive care medicine ; Male ; Medical sciences ; Middle Aged ; Nephrology ; Nephrology. Urinary tract diseases ; osteocalcin ; Osteocalcin - metabolism ; Phenotype ; phylloquinone ; Regression Analysis ; Renal Dialysis - adverse effects ; Vitamin K ; Vitamin K 1 - blood ; Vitamin K Deficiency - epidemiology ; Vitamin K Deficiency - genetics ; Vitamin K Deficiency - metabolism ; γ-carboxylation</subject><ispartof>American journal of kidney diseases, 2007-03, Vol.49 (3), p.432-439</ispartof><rights>National Kidney Foundation, Inc.</rights><rights>2007 National Kidney Foundation, Inc.</rights><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c439t-d275c1e2085bf51455a3eb7df9704eee39934175f0411c3f171199ef607fc7cb3</citedby><cites>FETCH-LOGICAL-c439t-d275c1e2085bf51455a3eb7df9704eee39934175f0411c3f171199ef607fc7cb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1053/j.ajkd.2006.11.041$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19100599$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17336705$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pilkey, Rachel M., MD</creatorcontrib><creatorcontrib>Morton, A. Ross, MD</creatorcontrib><creatorcontrib>Boffa, Michael B., PhD</creatorcontrib><creatorcontrib>Noordhof, Curtis</creatorcontrib><creatorcontrib>Day, Andrew G., MSc</creatorcontrib><creatorcontrib>Su, Yinghua, BSc</creatorcontrib><creatorcontrib>Miller, Lisa M., MD</creatorcontrib><creatorcontrib>Koschinsky, Marlys L., PhD</creatorcontrib><creatorcontrib>Booth, Sarah L., PhD</creatorcontrib><title>Subclinical Vitamin K Deficiency in Hemodialysis Patients</title><title>American journal of kidney diseases</title><addtitle>Am J Kidney Dis</addtitle><description>Background Subclinical vitamin K deficiency increasingly is associated with extraosseous calcification in healthy adults. Nondietary determinants of vitamin K status include apolipoprotein E (apoE) genotype, which may influence vitamin K transport to peripheral tissues. Methods Serum phylloquinone concentrations and percentage of uncarboxyated osteocalcin (%ucOC) were measured by means of high-performance liquid chromatography and radioimmunoassay in 142 hemodialysis patients, respectively. ApoE phenotype was determined by means of isoelectric focusing of delipidated serum samples and Western blot analysis. Clinical and laboratory data were obtained by using chart review. Results Mean age was 62.6 ± 14.8 (SD) years. Mean phylloquinone level was 0.99 ± 1.12 nmol/L; 29% of patients had levels less than 0.4 nmol/L. There was no association between phylloquinone level and %ucOC. There were positive correlations between phylloquinone and total cholesterol ( P = 0.017), triglyceride ( P = 0.022), and ionized calcium levels ( P = 0.019). There was a negative correlation between phylloquinone level and dialysis adequacy ( P = 0.002). Mean %ucOC was 51.1% ± 25.8%, and 93% of subjects had values greater than 20%. There were positive correlations between %ucOC and dialysis vintage ( P < 0.001), phosphate level ( P < 0.001), parathyroid hormone level ( P < 0.001), albumin level ( P = 0.035), and ionized calcium level ( P = 0.046). Seventeen percent of patients were apoE4. Mean %ucOC was significantly greater in apoE4 carriers compared with all other apoE phenotypes (60.1% ± 28.4% versus 47.8% ± 24.4%; P = 0.035). In multiple regression analysis with phylloquinone level forced in, independent predictors of %ucOC were phosphate level, dialysis vintage, parathyroid hormone level, and apoE4. Conclusion These data indicate suboptimal vitamin K status in hemodialysis patients, shown by low phylloquinone concentrations and high %ucOC in 29% and 93% of subjects, respectively. The apoE4 allele influences osteocalcin γ-carboxylation in hemodialysis patients.</description><subject>Aged</subject><subject>Alleles</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>apolipoprotein E</subject><subject>Apolipoproteins E - genetics</subject><subject>Apolipoproteins E - physiology</subject><subject>Biological and medical sciences</subject><subject>Biological Transport - physiology</subject><subject>Cohort Studies</subject><subject>Cross-Sectional Studies</subject><subject>Emergency and intensive care: renal failure. Dialysis management</subject><subject>Female</subject><subject>hemodialysis</subject><subject>Humans</subject><subject>Intensive care medicine</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Nephrology</subject><subject>Nephrology. Urinary tract diseases</subject><subject>osteocalcin</subject><subject>Osteocalcin - metabolism</subject><subject>Phenotype</subject><subject>phylloquinone</subject><subject>Regression Analysis</subject><subject>Renal Dialysis - adverse effects</subject><subject>Vitamin K</subject><subject>Vitamin K 1 - blood</subject><subject>Vitamin K Deficiency - epidemiology</subject><subject>Vitamin K Deficiency - genetics</subject><subject>Vitamin K Deficiency - metabolism</subject><subject>γ-carboxylation</subject><issn>0272-6386</issn><issn>1523-6838</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kV2L1TAQhoO4uMfVP-CF9Ebv2p1pmqYBEWT92MUFhVXxLqTpBNLtx5q0wvn3pp4jC3vhVRjyvDPDM4y9QCgQBD_vC9PfdkUJUBeIBVT4iO1QlDyvG948ZjsoZZnXvKlP2dMYewBQvK6fsFOUnNcSxI6pm7W1g5-8NUP2wy9m9FP2OXtPzltPk91nqb6kce68GfbRx-yrWdLHEp-xE2eGSM-P7xn7_vHDt4vL_PrLp6uLd9e5rbha8q6UwiKV0IjWCayEMJxa2TkloSIirhSvUAqX1kfLHUpEpcjVIJ2VtuVn7PWh712Yf60UFz36aGkYzETzGrWEEpUQKoHlAbRhjjGQ03fBjybsNYLehOleb8L0Jkwj6jQxhV4eu6_tSN195GgoAa-OgInJkQtmsj7ecwoBhNqmvzlwlFz89hR0_CuQOh_ILrqb_f_3ePsg_u8qt7Sn2M9rmJJljTqWGvTNdtrtslADNlz85H8A7RuciA</recordid><startdate>20070301</startdate><enddate>20070301</enddate><creator>Pilkey, Rachel M., MD</creator><creator>Morton, A. Ross, MD</creator><creator>Boffa, Michael B., PhD</creator><creator>Noordhof, Curtis</creator><creator>Day, Andrew G., MSc</creator><creator>Su, Yinghua, BSc</creator><creator>Miller, Lisa M., MD</creator><creator>Koschinsky, Marlys L., PhD</creator><creator>Booth, Sarah L., PhD</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20070301</creationdate><title>Subclinical Vitamin K Deficiency in Hemodialysis Patients</title><author>Pilkey, Rachel M., MD ; Morton, A. Ross, MD ; Boffa, Michael B., PhD ; Noordhof, Curtis ; Day, Andrew G., MSc ; Su, Yinghua, BSc ; Miller, Lisa M., MD ; Koschinsky, Marlys L., PhD ; Booth, Sarah L., PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c439t-d275c1e2085bf51455a3eb7df9704eee39934175f0411c3f171199ef607fc7cb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Aged</topic><topic>Alleles</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>apolipoprotein E</topic><topic>Apolipoproteins E - genetics</topic><topic>Apolipoproteins E - physiology</topic><topic>Biological and medical sciences</topic><topic>Biological Transport - physiology</topic><topic>Cohort Studies</topic><topic>Cross-Sectional Studies</topic><topic>Emergency and intensive care: renal failure. Dialysis management</topic><topic>Female</topic><topic>hemodialysis</topic><topic>Humans</topic><topic>Intensive care medicine</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Nephrology</topic><topic>Nephrology. Urinary tract diseases</topic><topic>osteocalcin</topic><topic>Osteocalcin - metabolism</topic><topic>Phenotype</topic><topic>phylloquinone</topic><topic>Regression Analysis</topic><topic>Renal Dialysis - adverse effects</topic><topic>Vitamin K</topic><topic>Vitamin K 1 - blood</topic><topic>Vitamin K Deficiency - epidemiology</topic><topic>Vitamin K Deficiency - genetics</topic><topic>Vitamin K Deficiency - metabolism</topic><topic>γ-carboxylation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pilkey, Rachel M., MD</creatorcontrib><creatorcontrib>Morton, A. Ross, MD</creatorcontrib><creatorcontrib>Boffa, Michael B., PhD</creatorcontrib><creatorcontrib>Noordhof, Curtis</creatorcontrib><creatorcontrib>Day, Andrew G., MSc</creatorcontrib><creatorcontrib>Su, Yinghua, BSc</creatorcontrib><creatorcontrib>Miller, Lisa M., MD</creatorcontrib><creatorcontrib>Koschinsky, Marlys L., PhD</creatorcontrib><creatorcontrib>Booth, Sarah L., PhD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of kidney diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pilkey, Rachel M., MD</au><au>Morton, A. Ross, MD</au><au>Boffa, Michael B., PhD</au><au>Noordhof, Curtis</au><au>Day, Andrew G., MSc</au><au>Su, Yinghua, BSc</au><au>Miller, Lisa M., MD</au><au>Koschinsky, Marlys L., PhD</au><au>Booth, Sarah L., PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Subclinical Vitamin K Deficiency in Hemodialysis Patients</atitle><jtitle>American journal of kidney diseases</jtitle><addtitle>Am J Kidney Dis</addtitle><date>2007-03-01</date><risdate>2007</risdate><volume>49</volume><issue>3</issue><spage>432</spage><epage>439</epage><pages>432-439</pages><issn>0272-6386</issn><eissn>1523-6838</eissn><abstract>Background Subclinical vitamin K deficiency increasingly is associated with extraosseous calcification in healthy adults. Nondietary determinants of vitamin K status include apolipoprotein E (apoE) genotype, which may influence vitamin K transport to peripheral tissues. Methods Serum phylloquinone concentrations and percentage of uncarboxyated osteocalcin (%ucOC) were measured by means of high-performance liquid chromatography and radioimmunoassay in 142 hemodialysis patients, respectively. ApoE phenotype was determined by means of isoelectric focusing of delipidated serum samples and Western blot analysis. Clinical and laboratory data were obtained by using chart review. Results Mean age was 62.6 ± 14.8 (SD) years. Mean phylloquinone level was 0.99 ± 1.12 nmol/L; 29% of patients had levels less than 0.4 nmol/L. There was no association between phylloquinone level and %ucOC. There were positive correlations between phylloquinone and total cholesterol ( P = 0.017), triglyceride ( P = 0.022), and ionized calcium levels ( P = 0.019). There was a negative correlation between phylloquinone level and dialysis adequacy ( P = 0.002). Mean %ucOC was 51.1% ± 25.8%, and 93% of subjects had values greater than 20%. There were positive correlations between %ucOC and dialysis vintage ( P < 0.001), phosphate level ( P < 0.001), parathyroid hormone level ( P < 0.001), albumin level ( P = 0.035), and ionized calcium level ( P = 0.046). Seventeen percent of patients were apoE4. Mean %ucOC was significantly greater in apoE4 carriers compared with all other apoE phenotypes (60.1% ± 28.4% versus 47.8% ± 24.4%; P = 0.035). In multiple regression analysis with phylloquinone level forced in, independent predictors of %ucOC were phosphate level, dialysis vintage, parathyroid hormone level, and apoE4. Conclusion These data indicate suboptimal vitamin K status in hemodialysis patients, shown by low phylloquinone concentrations and high %ucOC in 29% and 93% of subjects, respectively. The apoE4 allele influences osteocalcin γ-carboxylation in hemodialysis patients.</abstract><cop>Orlando, FL</cop><pub>Elsevier Inc</pub><pmid>17336705</pmid><doi>10.1053/j.ajkd.2006.11.041</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0272-6386 |
ispartof | American journal of kidney diseases, 2007-03, Vol.49 (3), p.432-439 |
issn | 0272-6386 1523-6838 |
language | eng |
recordid | cdi_proquest_miscellaneous_70219559 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Aged Alleles Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy apolipoprotein E Apolipoproteins E - genetics Apolipoproteins E - physiology Biological and medical sciences Biological Transport - physiology Cohort Studies Cross-Sectional Studies Emergency and intensive care: renal failure. Dialysis management Female hemodialysis Humans Intensive care medicine Male Medical sciences Middle Aged Nephrology Nephrology. Urinary tract diseases osteocalcin Osteocalcin - metabolism Phenotype phylloquinone Regression Analysis Renal Dialysis - adverse effects Vitamin K Vitamin K 1 - blood Vitamin K Deficiency - epidemiology Vitamin K Deficiency - genetics Vitamin K Deficiency - metabolism γ-carboxylation |
title | Subclinical Vitamin K Deficiency in Hemodialysis Patients |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T00%3A22%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Subclinical%20Vitamin%20K%20Deficiency%20in%20Hemodialysis%20Patients&rft.jtitle=American%20journal%20of%20kidney%20diseases&rft.au=Pilkey,%20Rachel%20M.,%20MD&rft.date=2007-03-01&rft.volume=49&rft.issue=3&rft.spage=432&rft.epage=439&rft.pages=432-439&rft.issn=0272-6386&rft.eissn=1523-6838&rft_id=info:doi/10.1053/j.ajkd.2006.11.041&rft_dat=%3Cproquest_cross%3E70219559%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70219559&rft_id=info:pmid/17336705&rft_els_id=S027263860601835X&rfr_iscdi=true |